Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122016) titled 'Population Pharmacokinetics and Dosage Optimization of Imipenem in Patients with Sepsis Undergoing Hemoperfusion' on April 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Harbin Medical University Affiliated First Hospital
Condition:
Sepsis
Intervention:
Blood perfusion group A:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-12-05
Target Sample Size: Blood perfusion group A:15;Blood perfusion group B:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=289961
Published by HT Digital C...